Rat Model Market size to exceed $1.8bn by 2025

Rat Model Market size is set to exceed USD 1.8 billion by 2025; according to a new research report by Global Market Insights, Inc.
 

Increase in usage of rat models in biological, physiological, pathological, and research studies will enhance the rat model market growth over the forthcoming years. The rapid market growth is owing to the genetic similarities, functional resemblances and physiological traits of the rats to the human body. Hence, the aforementioned factors will play a significant role in enhancing the market outlook in the near future.

 

Request Sample Buy NowInquiry Before Buying

 

Increase in number of animal testing procedures on rat models for ensuring drug safety and cognitive research will boost the industry growth

Growing preference of rat model in research and development is expected to boost the market trends in the upcoming years. For diabetes research, rat model is specifically considered since this model have been useful for understanding the mechanism of the disease. Furthermore, growing usage of rat models in understanding autoimmune diseases are also contributing in the market growth significantly. Rat models are also used to study the safety and efficacy of the drugs that humans are exposed to or use regularly. However, there are numerous factors that are obstructing the market growth such as guidelines, strict regulations and opposition on testing on rat models by several organization across the globe.
 

Browse key industry insights spread across 450 pages with 376 market data tables & 11 figures & charts from the report, “Rat Model Market Size By Rat Type (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell, Nuclear Transfer), By Application (Research & Development, {Infectious Disease, Immunological Disease, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases}, Production And Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-Government}, Academic And Research Institutes, Contract Research Organizations) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Switzerland, Netherlands, Czech Republic, Poland, Belgium, Finland, Hungary, Denmark, Ireland, Sweden, China, Japan, Australia, South Korea, New Zealand, Taiwan, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Israel), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/rat-model-market
 

Frequent use of animal testing on knockout models will enhance the industry demand

Based on the type of animal, the market is segmented as inbred, outbred, knockout, hybrid and others. Knockout model market is estimated to witness a fastest growth at around 9% CAGR over the forecast period. Knockout models are currently in high demand owing to several attributes it acquires. For instance, knockout models mimic human diseases and are considered as an essential tool for studying drug discovery & development, and gene function. These knockout models are used to advance various areas of medical research including psychiatric disorders, diabetes, cardiovascular and autoimmune disorders. Hence, owing to these factors knockout model is projected to witness a significant growth in the upcoming years.
 

Embryonic stem cell injection technology is expected to pave attractive growth opportunities for researchers in genetically modifying animals

Based on technology, the market is segmented as CRISPR, embryonic stem cell injection, microinjection, nuclear transfer and others. Embryonic stem cell injection in rat testing is estimated to witness around 8% growth over the forecast period. The high growth rate is owing to the several advantages rat offers over mice in behavior, transplantation and pharmacokinetic studies. These genetically modified rat models are used in biomedical research that helps in identifying the number of diseases that harm humans. Hence, aforementioned factors are expected to propel the market growth in the upcoming years.
 

Increasing statistics of anatomical and physiological similarities between rats and humans will boost the market demand

On the basis of application of rat models, the market is segmented as research and development, academics, production and quality control and, others. The research and development segment is further sub segmented as infectious disease, immunological diseases, cancer, diabetes, cardiovascular diseases, genetic diseases, neurological diseases and others. Application of rat model in academic studies was valued at around USD 18.6 million in the year 2018. Growing usage of laboratory rat for academic studies will foster the rat model market demand. The upsurge of rat model for biomedical research has further uplifted the market outlook. This is due to the anatomical, physiological and genetic similarities between the rats and humans that has resulted in encouraging the researchers to study several basic and fundamental biological research studies in rat models before applying them on humans. Hence, increase in number of rat models for studying behavioral and function science is expected to boost the segmental growth.
 

Veterinary research is set to proceed promptly due to ongoing treatment for the animals on rat model which will further spur the market growth

The use segment is segregated as veterinary and human. The use of rat model in veterinary research is projected to grow at around 7.5% CAGR over the forecast period. This is owing to the fact that animal research testing has saved the lives of millions of companion animals. For instance, rabies, infectious hepatitis, vaccine to prevent distemper, tetanus, parvovirus among others are some of the diseases for which research has been conducted on rat model. Hence, owing to these statements veterinary research is expected to impel the segmental growth in the upcoming years.
 

Contract research organizations will emerge as the centerpiece for the growth of rat model industry size

Based on end-use segment, the rat model market is segmented as companies, academic and research institutes, organizations, and contract research organizations (CROs). The adoption of rat models in the contract research organizations was estimated at around USD 80 million in the year 2018. Increase in demand and adoption rate of rat models by the contract research organizations for research and development activity will enhance the business growth in the near future. Several researches are conducted on rat model in CROs in order to procure knowledge regarding numerous diseases such as immunological disfunction, transplantation, aging, carcinogenesis, among others. Hence, these factors are significantly contributing into the adoption of rat models thereby propelling the market growth positively.
 

UK dominated the Europe rat model market with more than 30% market share owing to growing use of rat models in research activities

UK dominated the Europe rat model market with around 30% of European industry in the year 2018. Demand for rat models in UK is growing with each passing year in order to understand the biological behavior of diseases. According to the recently published article, in 2019, majority of experimental procedures were carried out on animals in 2017, among which 230,000 rats were used. Rats models in UK has been used to research several diseases such as cardiovascular diseases and Alzheimer’s. Hence, growing research and development activities will supplement the adoption rate of rat models, thereby, fueling the business growth in the near future.
 

Increase in strategic initiatives such as acquisitions, mergers, partnerships and collaborations by major industry players will enhance the rat model market growth in future

Prominent market players in the rat model industry include Envigo, genOway, Charles River, Horizon Discovery Group plc, Biomere, Transviragen Inc., Janvier Labs, Taconic Biosciences Inc. and Transpogen Biopharmaceutical, Inc. The key industry players focus on several major strategies such as acquisition, merger, new product development and launch in order to improve their product portfolio and geographical expansion. For instance, In January 2019, Horizon Discovery Group plc announced that it would extend its CRISPR Screening Service further including ex vivo T lymphocytes. This extension met the requirements of immunology-based research in drug discovery and also will enable to identify new gene targets.
 

Explore More on Related Topics:

Infographics

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X